본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer LIM MYONG CHEOL
(Rare & Pediatric Cancer Branch)

LIM MYONG CHEOL
(Rare & Pediatric Cancer Branch)
. CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025-01-21; 2025; 36(1):e73~. IF 3.7 (2024)
The Longitudinal Effect of Sugar-Sweetened Beverage Consumption and Risk of All-Cause and Cause-Specific Mortality in Korean Adults: Results From the Health Examinees Study Kim Byung Mi
(Division of Cancer Prevention)

Jung Hye In
(Division of Cancer Prevention)
. The Longitudinal Effect of Sugar-Sweetened Beverage Consumption and Risk of All-Cause and Cause-Specific Mortality in Korean Adults: Results From the Health Examinees Study. JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION. 2025-01-21; 2025; :~. IF 2.6 (2024)
Youth-targeted alcohol control policies and adolescent suicide: An interrupted time-series analysis Kim Byung Mi
(Division of Cancer Prevention)

Kim Tae Wol
(Division of Cancer Prevention)
. Youth-targeted alcohol control policies and adolescent suicide: An interrupted time-series analysis. DRUG AND ALCOHOL DEPENDENCE. 2025-01-20; 2025; 268:112557~. IF 3.6 (2024)
Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors Kim Sang Soo
(Radiological Science？Branch)

Baek, Hye Jung
(Radiological Science？Branch)
. Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors. CANCER COMMUNICATIONS. 2025-01-18; 2025; 45(4):486~490. IF 24.9 (2024)
Two Cysteines in Raf Kinase Inhibitor Protein Make Differential Contributions to Structural Dynamics In Vitro You Hye Jin
(Cancer？Microenvironment Branch)

cho hyun sang
(Cancer？Microenvironment Branch)
. Two Cysteines in Raf Kinase Inhibitor Protein Make Differential Contributions to Structural Dynamics In Vitro. MOLECULES. 2025-01-17; 2025; 30(2):384~. IF 4.6 (2024)
Association of long-term exposure to ambient air pollution with osteoporosis among cancer survivors: Results from the Korea National Health and Nutrition Examination Survey Kim Hyun Jin
(Data Link & Operation Team)

Hwang Ju Yeon
(Data Link & Operation Team)
. Association of long-term exposure to ambient air pollution with osteoporosis among cancer survivors: Results from the Korea National Health and Nutrition Examination Survey. PREVENTIVE MEDICINE. 2025-01-17; 2025; 192:108228~. IF 3.2 (2024)
Risk of Osteoporotic Fractures among Patients with Thyroid Cancer: A Nationwide Population-Based Cohort Study Lee Eun Kyung
(Targeted Therapy Branch)


()
. Risk of Osteoporotic Fractures among Patients with Thyroid Cancer: A Nationwide Population-Based Cohort Study. ENDOCRINOLOGY AND METABOLISM. 2025-01-15; 2025; 40(2):225~235. IF 4.2 (2024)
Gender differences in awareness and practices of cancer prevention recommendations in Korea: a cross-sectional survey Kim Byung Mi
(Division of Cancer Prevention)

Choi Yoon Joo
(Division of Cancer Prevention)
. Gender differences in awareness and practices of cancer prevention recommendations in Korea: a cross-sectional survey. EPIDEMIOLOGY AND HEALTH. 2025-01-15; 2025; 47:e2025003~. IF 2.2 (2024)
Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea Ki, Moran
(Department of Cancer Control and Population Health)

Choi Hwa Young
(Department of Cancer Control and Population Health)
. Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea. JOURNAL OF INFECTION AND PUBLIC HEALTH. 2025-01-13; 2025; 18(3):102662~. IF 4 (2024)
A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.) KIM YOUNG WOO
(Department of Public Health & AI)


()
. A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.). EJSO. 2025-01-10; 2025; 51(5):109593~. IF 2.9 (2024)
First page Prev paging 11 12 13 14 15 16 17 18 19 20 next paging last page